The Europe OTC Drug and Dietary Supplement market was valued at US$ 85,835.9 million in 2019 and is projected to reach US$ 141,676.3 million by 2027; it is expected to grow at a CAGR of 6.6% during 2020–2027.
The growth of the OTC Drug and Dietary Supplement market is mainly attributed to the factors such as rising general health issues, and preference of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs is the major factor hindering the market growth.
Request Sample Copy Of this Report @ https://www.theinsightpartners.com/sample/TIPRE00013997/
EUROPE OTC DRUG AND DIETARY SUPPLEMENT – MARKET SEGMENTATION
OTC drug and Dietary Supplement– By Product
- Cough and Cold Products
- Vitamins and Dietary Supplements
- Gastrointestinal Products
- Sleep Aids
- Oral Care Products
- Ophthalmic Products
- Feminine Care
OTC Drug and Dietary Supplement– By Type
Purchase Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00013997/
The Germany has observed the fastest growth in the OTC Drug and Dietary Supplement market within the past few years and is expected to lead the market in Europe during the forecast period. The market for OTC drug and dietary supplements is expected to grow due to growing awareness about health and fitness, the ever-increasing geriatric population, and spending out–of–pocket. Furthermore, innovations and increased product launches have fueled market growth in recent years. The market has experienced increased sales in the products for cold, pain management, gastrointestinal diseases, influenza, and dietary supplements such as vitamins and herbal products.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
Email: [email protected]